MGP Ingredients Inc's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), MGP Ingredients Inc reported revenue of $536.4M (-23.8% year on year) and net income of ($107.8M) (-412.9% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Sales | $536.4M | $703.6M | $836.5M | $782.4M |
| Cost of sales | $337.0M | $417.3M | $531.8M | $529.1M |
| Gross profit | $199.4M | $286.3M | $304.7M | $253.3M |
| Advertising and promotion expenses | $31.1M | $40.5M | $38.2M | $29.7M |
| Selling, general, and administrative expenses | $84.8M | $81.4M | $91.4M | $74.6M |
| Impairment of long-lived assets and other | $0 | $137.0K | $19.4M | — |
| Goodwill and indefinite-lived intangible asset impairment | $152.6M | — | — | — |
| Change in fair value of contingent consideration | $25.5M | $16.1M | $7.1M | — |
| Operating income (loss) | ($94.6M) | $74.4M | $148.6M | $149.0M |
| Interest expense, net | ($7.0M) | ($8.4M) | ($6.6M) | ($5.5M) |
| Other income (expense), net | $1.3M | $2.5M | ($220.0K) | ($3.3M) |
| Income (loss) before income taxes | ($100.3M) | $68.4M | $141.7M | $140.2M |
| Income tax expense | $7.5M | $34.0M | $34.6M | $31.3M |
| Net income (loss) | ($107.8M) | $34.5M | $107.1M | $108.9M |
| Net loss attributable to noncontrolling interest | $23.0K | $198.0K | $345.0K | $590.0K |
| Net income (loss) attributable to MGP Ingredients, Inc. | ($107.8M) | $34.7M | $107.5M | $109.5M |
| Income (loss) attributable to participating securities, basic | ($1.3M) | ($373.0K) | ($1.1M) | ($871.0K) |
| Income (loss) attributable to participating securities, diluted | ($1.3M) | ($373.0K) | ($1.1M) | ($871.0K) |
| Net income (loss) used in earnings per common share calculation, basic | ($106.5M) | $34.3M | $106.4M | $108.6M |
| Net income (loss) used in earnings per common share calculation, diluted | ($106.5M) | $34.3M | $106.4M | $108.6M |
| Basic (in shares) | 21.4M | 22.0M | 22.1M | 22.0M |
| Diluted (in shares) | 21.4M | 22.0M | 22.2M | 22.1M |
| Basic (in dollars per share) | -$4.99 | $1.56 | $4.82 | $4.94 |
| Diluted (in dollars per share) | -$4.99 | $1.56 | $4.80 | $4.92 |
| Line item | Jun 30, 2026 · Q2 | Mar 31, 2026 · Q1 | Sep 30, 2025 · Q3 | Jun 30, 2025 · Q2 |
|---|---|---|---|---|
| Sales | $124.4M | $106.4M | $130.9M | $145.5M |
| Cost of sales | $77.9M | $72.8M | $81.5M | $87.1M |
| Gross profit | $46.5M | $33.6M | $49.4M | $58.4M |
| Advertising and promotion expenses | $5.7M | $6.2M | $6.7M | $6.9M |
| Selling, general, and administrative expenses | $20.2M | $21.1M | $18.9M | $23.2M |
| Impairment and other | $751.0K | — | — | — |
| Provision for credit loss | $2.1M | — | — | — |
| Change in fair value of contingent consideration | $0 | $0 | $2.8M | $8.0M |
| Operating income (loss) | $17.7M | ($173.2M) | $21.0M | $20.3M |
| Interest expense, net | ($2.9M) | ($1.4M) | ($1.7M) | ($1.9M) |
| Other income, net | $299.0K | ($50.0K) | $428.0K | $314.0K |
| Income (loss) before income taxes | $15.1M | ($174.7M) | $19.7M | $18.7M |
| Income tax expense (benefit) | $3.1M | ($39.9M) | $4.3M | $4.3M |
| Net income (loss) | $12.0M | ($134.8M) | $15.4M | $14.4M |
| Attributable to noncontrolling interest | $0 | $3.0K | ($7.0K) | ($1.0K) |
| Net income (loss) attributable to MGP Ingredients, Inc. | $12.0M | ($134.8M) | $15.4M | $14.4M |
| Attributable to participating securities, basic | ($155.0K) | ($35.0K) | ($190.0K) | ($159.0K) |
| Attributable to participating securities, diluted | ($155.0K) | ($35.0K) | ($190.0K) | ($159.0K) |
| Net income (loss) used in earnings per common share calculation, basic | $11.9M | ($134.8M) | $15.2M | $14.3M |
| Net income (loss) used in earnings per common share calculation, diluted | $11.9M | ($134.8M) | $15.2M | $14.3M |
| Basic (in shares) | 21.4M | 21.4M | 21.4M | 21.4M |
| Diluted (in shares) | 21.4M | 21.4M | 21.4M | 21.4M |
| Basic (in dollars per share) | $0.55 | -$6.30 | $0.71 | $0.67 |
| Diluted (in dollars per share) | $0.55 | -$6.30 | $0.71 | $0.67 |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $18.5M | $25.3M | $18.4M | $47.9M |
| Receivables (less allowance for credit loss of $1,190 and $1,875 at December 31, 2025 and 2024, respectively) | $116.2M | $148.5M | $144.3M | $109.3M |
| Inventory | $382.7M | $364.9M | $346.9M | $289.7M |
| Prepaid expenses | $2.1M | $4.0M | $3.6M | $3.0M |
| Refundable income taxes | $3.2M | $3.4M | $1.2M | $4.3M |
| Total current assets | $522.7M | $546.1M | $514.3M | $454.2M |
| Property, plant, and equipment, net | $328.0M | $316.7M | $262.3M | $235.6M |
| Operating lease right-of-use assets, net | $13.8M | $15.5M | $14.0M | $15.0M |
| Investment in joint venture | $8.2M | $7.0M | $5.2M | $5.5M |
| Intangible assets, net | $244.7M | $268.5M | $271.7M | $216.8M |
| Goodwill | $115.7M | $247.8M | $321.5M | $226.3M |
| Other assets | $2.7M | $4.2M | $3.3M | $4.8M |
| Total assets | $1.2B | $1.4B | $1.4B | $1.2B |
| Current maturities of long-term debt | $6.4M | $6.4M | $6.4M | $5.6M |
| Accounts payable | $54.6M | $66.3M | $73.6M | $66.4M |
| Contingent consideration | $110.8M | $85.3M | $69.2M | — |
| Federal and state excise taxes payable | $5.8M | $5.4M | $2.3M | $4.6M |
| Accrued expenses and other | $22.5M | $14.4M | $31.9M | $28.7M |
| Total current liabilities | $200.1M | $92.5M | $114.1M | $105.4M |
| Long-term debt, less current maturities | $49.7M | $121.3M | $85.3M | $29.5M |
| Convertible senior notes | $196.2M | $195.9M | $195.5M | $195.2M |
| Long-term operating lease liabilities | $10.6M | $11.9M | $11.3M | $11.6M |
| Contingent consideration | $0 | — | — | — |
| Other noncurrent liabilities | $2.5M | $3.0M | $4.8M | $3.7M |
| Deferred income taxes | $60.0M | $63.4M | $63.1M | $67.1M |
| Total liabilities | $519.1M | $573.2M | $543.3M | $412.6M |
| Preferred, 5% non-cumulative; $10 par value; authorized 1,000 shares; issued and outstanding 437 shares | 4.0K | 4.0K | 4.0K | 4.0K |
| No par value; authorized 40,000,000 shares; issued 23,125,166 shares at December 31, 2025 and 2024; 21,294,315 and 21,194,707 shares outstanding at December 31, 2025 and 2024, respectively | 6.7M | 6.7M | 6.7M | 6.7M |
| Additional paid-in capital | $330.9M | $332.2M | $325.5M | $318.8M |
| Retained earnings | $445.7M | $563.9M | $539.9M | $443.1M |
| Accumulated other comprehensive loss | ($373.0K) | ($658.0K) | ($397.0K) | ($304.0K) |
| Treasury stock, at cost, 1,830,851 and 1,930,459 shares at December 31, 2025 and 2024, respectively | -64.5M | -68.0M | -21.2M | — |
| Total MGP Ingredients, Inc. stockholders’ equity | $718.4M | $834.2M | $850.5M | $746.7M |
| Noncontrolling interest | ($1.6M) | ($1.6M) | ($1.4M) | ($1.1M) |
| Total equity | $716.8M | $832.5M | $849.1M | $745.6M |
| Total liabilities and equity | $1.2B | $1.4B | $1.4B | $1.2B |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $17.8M | $10.4M | $13.4M | $17.3M |
| Receivables, net (less allowance for credit loss of $3,338 and $1,190 at June 30, 2026, and December 31, 2025, respectively) | $103.6M | $86.6M | $106.7M | $117.2M |
| Inventory | $408.4M | $403.1M | $384.5M | $379.7M |
| Prepaid expenses | $5.1M | $5.8M | $4.1M | $5.7M |
| Refundable income taxes | $0 | $134.0K | $2.0M | $320.0K |
| Total current assets | $534.8M | $506.0M | $510.8M | $520.2M |
| Property, plant, and equipment | $574.2M | $569.7M | $588.4M | $581.9M |
| Less accumulated depreciation and amortization | ($277.8M) | ($272.2M) | ($261.5M) | ($256.1M) |
| Property, plant, and equipment, net | $296.4M | $297.5M | $327.0M | $325.8M |
| Operating lease right-of-use assets, net | $11.1M | $11.9M | $14.8M | $15.3M |
| Investment in joint venture | $6.9M | $6.7M | $7.9M | $7.5M |
| Intangible assets, net | $206.1M | $206.9M | $266.0M | $266.8M |
| Goodwill | $0 | $0 | $247.8M | $247.8M |
| Other assets | $2.5M | $2.2M | $2.7M | $2.7M |
| Total assets | $1.1B | $1.0B | $1.4B | $1.4B |
| Current maturities of long-term debt | $6.4M | $6.4M | $6.4M | $6.4M |
| Accounts payable | $47.9M | $49.8M | $42.7M | $41.9M |
| Contingent consideration | $0 | $110.8M | $110.8M | $108.0M |
| Federal and state excise taxes payable | $4.5M | $3.7M | $2.5M | $3.9M |
| Income taxes payable | $3.2M | — | — | — |
| Accrued expenses and other | $14.5M | $14.4M | $21.6M | $18.4M |
| Total current liabilities | $76.5M | $185.0M | $183.9M | $178.6M |
| Long-term debt, less current maturities | $166.9M | $42.3M | $66.2M | $94.7M |
| Convertible senior notes | $196.3M | $196.3M | $196.1M | $196.0M |
| Long-term operating lease liabilities | $8.2M | $9.0M | $11.5M | $11.8M |
| Other noncurrent liabilities | $2.8M | $2.2M | $2.4M | $2.3M |
| Deferred income taxes | $16.3M | $16.9M | $63.4M | $62.5M |
| Total liabilities | $466.9M | $451.7M | $523.5M | $545.9M |
| Preferred, 5% non-cumulative; $10 par value; authorized 1,000 shares; issued and outstanding 437 shares | 4.0K | 4.0K | 4.0K | 4.0K |
| No par value; authorized 40,000,000 shares; issued 23,125,166 shares at June 30, 2026 and December 31, 2025; and 21,411,844 and 21,294,315 shares outstanding at June 30, 2026 and December 31, 2025, respectively | 6.7M | 6.7M | 6.7M | 6.7M |
| Additional paid-in capital | $328.0M | $328.5M | $330.1M | $329.3M |
| Retained earnings | $317.7M | $308.3M | $583.0M | $570.2M |
| Accumulated other comprehensive loss | ($746.0K) | ($638.0K) | ($10.0K) | $255.0K |
| Treasury stock, at cost, 1,713,322 and 1,830,851 shares at June 30, 2026 and December 31, 2025, respectively | -60.8M | -61.6M | -64.6M | -64.6M |
| Total MGP Ingredients, Inc. stockholders’ equity | $590.8M | $581.3M | $855.2M | $841.8M |
| Noncontrolling interest | $0 | ($1.6M) | ($1.6M) | ($1.7M) |
| Total equity | $590.8M | $579.6M | $853.5M | $840.1M |
| Total liabilities and equity | $1.1B | $1.0B | $1.4B | $1.4B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net income (loss) | ($107.8M) | $34.5M | $107.1M | $108.9M |
| Depreciation and amortization | $24.1M | $22.0M | $22.1M | $21.5M |
| Impairment of long-lived assets and other | $0 | $137.0K | $19.4M | — |
| Goodwill and indefinite-lived intangible asset impairment | $152.6M | — | — | — |
| Share-based compensation | $4.7M | $4.0M | $10.6M | $5.5M |
| Equity method investment loss (gain) | ($1.2M) | ($1.8M) | $337.0K | $2.2M |
| Deferred income taxes, including change in valuation allowance | ($3.4M) | $359.0K | ($4.0M) | $1.0M |
| Change in fair value of contingent consideration | $25.5M | $16.1M | $7.1M | — |
| Other, net | $831.0K | $465.0K | $728.0K | $194.0K |
| Receivables, net | $32.2M | ($4.4M) | ($32.4M) | ($16.8M) |
| Inventory | ($18.1M) | ($18.2M) | ($46.9M) | ($44.4M) |
| Prepaid expenses | $1.8M | ($409.0K) | ($481.0K) | ($1.5M) |
| Income taxes payable (refundable) | $239.0K | ($2.3M) | $3.1M | $1.2M |
| Accounts payable | $1.6M | ($9.1M) | ($2.4M) | $10.6M |
| Accrued expenses and other | $8.4M | ($15.1M) | $348.0K | $2.0M |
| Federal and state excise taxes payable | $397.0K | $3.1M | ($2.4M) | ($2.4M) |
| Other, net | ($330.0K) | ($881.0K) | $1.5M | $829.0K |
| Net cash provided by operating activities | $121.5M | $102.3M | $83.8M | $88.9M |
| Additions to property, plant, and equipment | ($45.5M) | ($71.2M) | ($55.3M) | ($45.3M) |
| Purchase of business, net of cash acquired | $0 | $0 | ($103.7M) | $0 |
| Other, net | ($37.0K) | ($377.0K) | ($263.0K) | $170.0K |
| Net cash used in investing activities | ($45.5M) | ($71.6M) | ($159.2M) | ($47.8M) |
| Payment of dividends and dividend equivalents | ($10.3M) | ($10.6M) | ($10.7M) | ($10.6M) |
| Repurchase of Common Stock | ($1.0M) | ($48.8M) | ($801.0K) | ($715.0K) |
| Loan fees paid related to borrowings | ($2.8M) | — | $0 | $0 |
| Proceeds from long-term debt | $28.0M | $125.0M | — | — |
| Principal payments on long-term debt | ($97.4M) | ($89.4M) | ($5.6M) | ($3.4M) |
| Net cash provided by (used in) financing activities | ($83.5M) | ($23.8M) | $45.9M | ($14.8M) |
| Effect of exchange rate changes on cash and cash equivalents | $706.0K | ($32.0K) | $34.0K | ($38.0K) |
| Increase (decrease) in cash and cash equivalents | ($6.8M) | $6.9M | ($29.5M) | $26.3M |
| Cash and cash equivalents, beginning of year | $25.3M | $18.4M | $47.9M | $21.6M |
| Cash and cash equivalents, end of year | $18.5M | $25.3M | $18.4M | $47.9M |
| Line item | Jun 30, 2026 · YTD | Mar 31, 2026 · Q1 | Sep 30, 2025 · YTD | Jun 30, 2025 · YTD |
|---|---|---|---|---|
| Net income (loss) | ($122.8M) | ($134.8M) | $26.8M | $11.4M |
| Depreciation and amortization | $12.7M | $6.3M | $17.8M | $11.6M |
| Goodwill and other long-lived assets impairment | $179.5M | $179.5M | — | — |
| Share-based compensation | $2.3M | $673.0K | $3.3M | $2.0M |
| Equity method investment gain | ($150.0K) | $19.0K | ($869.0K) | ($494.0K) |
| Deferred income taxes, including change in valuation allowance | ($43.7M) | ($43.2M) | ($25.0K) | ($901.0K) |
| Change in fair value of contingent consideration | $0 | $0 | $25.5M | $22.7M |
| Payment of contingent consideration | ($48.7M) | — | — | — |
| Other, net | $546.0K | $290.0K | $594.0K | $446.0K |
| Receivables, net | $12.5M | $29.4M | $41.7M | $31.1M |
| Inventory | ($25.6M) | ($20.3M) | ($19.9M) | ($15.2M) |
| Prepaid expenses | ($3.0M) | ($3.7M) | ($163.0K) | ($1.8M) |
| Income taxes payable | $6.4M | $3.1M | $1.4M | $3.1M |
| Accounts payable | ($2.5M) | ($1.3M) | ($8.4M) | ($10.7M) |
| Accrued expenses and other | ($7.0M) | ($6.8M) | $7.7M | $4.7M |
| Federal and state excise taxes payable | ($1.3M) | ($2.1M) | ($2.9M) | ($1.5M) |
| Other, net | $2.0K | ($227.0K) | ($74.0K) | ($159.0K) |
| Net cash provided by (used in) operating activities | ($40.7M) | $7.0M | $92.4M | $56.4M |
| Additions to property, plant, and equipment | ($10.2M) | ($5.7M) | ($40.7M) | ($32.2M) |
| Distributions from equity method investment | $1.5M | $1.5M | — | — |
| Other, net | $322.0K | $449.0K | ($14.0K) | ($11.0K) |
| Net cash used in investing activities | ($8.4M) | ($3.8M) | ($40.7M) | ($32.2M) |
| Payment of dividends and dividend equivalents | ($5.2M) | ($2.6M) | ($7.7M) | ($5.2M) |
| Repurchase of Common Stock | ($886.0K) | ($886.0K) | ($1.0M) | ($1.0M) |
| Loan fees paid related to borrowings | $0 | — | ($2.7M) | ($2.7M) |
| Proceeds from long-term debt | $145.0M | $10.0M | $28.0M | $28.0M |
| Principal payments on long-term debt | ($28.2M) | ($17.6M) | ($80.8M) | ($52.2M) |
| Payment of contingent consideration | ($62.1M) | — | — | — |
| Net cash provided by (used in) financing activities | $48.6M | ($11.1M) | ($64.3M) | ($33.1M) |
| Effect of exchange rate changes on cash and cash equivalents | ($155.0K) | ($201.0K) | $699.0K | $960.0K |
| Decrease in cash and cash equivalents | ($666.0K) | ($8.1M) | ($11.8M) | ($8.0M) |
| Cash and cash equivalents, beginning of period | $18.5M | $18.5M | $25.3M | $25.3M |
| Cash and cash equivalents, end of period | $17.8M | $10.4M | $13.4M | $17.3M |
MGP Ingredients Inc score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.